Professional Documents
Culture Documents
BY
KEZIAH DANJUMMA
1910502036
EPIDEMIOLOGY IN AFRICA
As of January 2022, specific and recent data on leptospirosis prevalence in Africa may be
limited. The disease has been reported in various African countries, but its prevalence varies
across regions. Challenges in surveillance and laboratory confirmation contribute to under
diagnosis and underreporting. Factors such as the presence of reservoir animals, environmental
conditions, and certain occupational activities contribute to leptospirosis prevalence. Limited
comprehensive studies and surveillance systems, coupled with low awareness and resources for
2 | MICROBIOLOY DEPARTMENT PRESENTATION BY KEZIAH DANJUMMA
disease monitoring, contribute to gaps in data on leptospirosis in many African countries. For the
latest information, it is advised to refer to the most recent studies or public health reports.
EPIDEMIOLOGY IN NIGERIA
As of January 2022, specific and up-to-date data on leptospirosis epidemiology in Nigeria is
limited. The disease is recognized in the country, with reported cases, but prevalence may vary
across regions. Underreporting is common due to limited awareness, diagnostic capabilities, and
surveillance systems. Risk factors include the presence of reservoir animals and environmental
conditions conducive to Leptospira bacteria survival, with certain occupational activities like
farming posing a higher risk. Similar to the broader African context, there are limitations in
comprehensive data on leptospirosis in Nigeria. Enhanced surveillance, increased awareness, and
research efforts are crucial to better understand the epidemiological landscape and implement
effective prevention and control measures. For the most current information, it is recommended
to refer to recent studies, public health reports, or contact relevant health authorities and research
institutions in Nigeria.
Conclusion:
In conclusion, addressing the complex challenges posed by leptospirosis requires a
multifaceted approach involving research, surveillance enhancement, targeted interventions, and
collaboration across disciplines. Investing in these areas will contribute to mitigating the impact
of leptospirosis on both human and animal populations, advancing global health efforts.
Reference:
Torgerson PR, Hagan JE, Costa F, et al.** (2015) Global Burden of Leptospirosis: Estimated in
Terms of Disability Adjusted Life Years.
Adler B, de la Peña Moctezuma A. (2010) Leptospira and leptospirosis. Veterinary
Microbiology, Costa F, Hagan JE, Calcagno J, et al. (2015) Global Morbidity and
Mortality of Leptospirosis: A Systematic Review.
Vincent AT, Schiettekatte O, Goarant C, et al. (2019) Revisiting the taxonomy and evolution of
pathogenicity of the genus Leptospira through the prism of genomics.
Cumberland P, Everard CO, Levett PN.** (2001) Assessment of the efficacy of an IgM-elisa and
microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis. The
American Journal of Tropical Medicine and Hygiene
Hagan JE, Moraga P, Costa F, et al.** (2016) Spatiotemporal Determinants of Urban
Leptospirosis Transmission: Four-Year Prospective Cohort Study of Slum Residents in
Brazil. PLoS Neglected Tropical Diseases
Goris MGA, Leeflang MMG, Boer KR, et al.** (2013) Establishment of Valid Laboratory Case
Definition for Human Leptospirosis. Clinical Microbiology and InfectionMicrobiology,